| Schedule of Issued and Outstanding Common Shares |
| | |
Note | |
Number | | |
Amount ($) | |
| Opening balance April 1, 2023 | |
3 | |
| - | | |
| 5,934,141 | |
| Share issuance to PGI | |
| |
| 1,338 | | |
| - | |
| Share issuance to NCAC shareholders | |
5 | |
| 2,086 | | |
| 37,336,416 | |
| Shares issued for debt settlement | |
| |
| 40 | | |
| 718,500 | |
| Shares issued to third party advisors | |
| |
| 119 | | |
| 2,136,340 | |
| Balance as at March 31, 2024 | |
| |
| 3,583 | | |
| 46,125,397 | |
| Shares issued on conversion of convertible note | |
17 | |
| 6,105 | | |
| 4,617,286 | |
| Shares issued on conversion of convertible note warrants | |
17 | |
| 3,660 | | |
| 639,954 | |
| Shares issued for ELOC | |
19 | |
| 35,024 | | |
| 6,692,495 | |
| Commitment shares ELOC | |
19 | |
| 543 | | |
| 187,500 | |
| Share issuance costs for ELOC | |
19 | |
| - | | |
| (469,600 | ) |
| Warrant exchange | |
13 | |
| 177 | | |
| 192,060 | |
| Shares issued to third party advisors | |
| |
| 94 | | |
| 241,379 | |
| Shares issued on conversion of PGI promissory notes | |
18 | |
| 7,562 | | |
| 988,569 | |
| Shares issued on conversion of NCAC promissory notes | |
18 | |
| 8,364 | | |
| 1,096,358 | |
| Shares issued for PsyLabs share exchange | |
11 | |
| 5,695 | | |
| 722,033 | |
| Shares issued for PIPE financing | |
20 | |
| 7,629 | | |
| 313,628 | |
| Share issuance costs for PIPE financing | |
20 | |
| - | | |
| (40,449 | ) |
| Shares issued for PIPE pre-funded warrants exercised | |
20 | |
| 12,447 | | |
| 511,690 | |
| Shares issuance costs for PIPE pre-funded warrants exercised | |
20 | |
| - | | |
| (65,995 | ) |
| Balance as at March 31, 2025 | |
| |
| 90,883 | | |
| 61,752,305 | |
| Shares issued to third party advisors | |
| |
| 2,439 | | |
| 60,000 | |
| Shares issued for ELOC | |
19 | |
| 1,051,973 | | |
| 14,545,896 | |
| Share issuance costs for ELOC | |
19 | |
| - | | |
| (581,836 | ) |
| Share issuance for Associate | |
11 | |
| 1,146,159 | | |
| 2,934,167 | |
| Exercise of RSUs | |
| |
| 1,823 | | |
| 37,451 | |
| Balance as at March 31, 2026 | |
| |
| 2,293,277 | | |
| 78,747,983 | |
|
| Schedule of Issued and Outstanding Warrants |
| |
| |
2025 | |
| Warrants | |
Note | |
Number | | |
Amount ($) | |
| Opening balance April 1, 2024 | |
| |
| - | | |
| - | |
| Warrants issued for convertible note Addendum | |
17 | |
| 134 | | |
| 42,528 | |
| Warrants issued for convertible note Termination Agreement | |
17 | |
| 3,660 | | |
| 639,954 | |
| Convertible note Termination Agreement warrants exercised | |
17 | |
| (3,660 | ) | |
| (639,954 | ) |
| PIPE financing warrant issuance | |
20 | |
| 52,597 | | |
| 1,686,372 | |
| PIPE financing warrant issuance costs | |
20 | |
| 1,506 | | |
| 137,778 | |
| Issuance costs for PIPE financing warrants | |
20 | |
| - | | |
| (355,278 | ) |
| PIPE pre-funded warrants exercised | |
20 | |
| (12,447 | ) | |
| (511,690 | ) |
| Issuance costs for PIPE pre-funded warrants exercised | |
20 | |
| - | | |
| 65,995 | |
| Balance as at March 31, 2025 and 2026 | |
| |
| 41,790 | | |
| 1,065,705 | |
|
| Schedule of Warrants were Outstanding and Exercisable |
The following warrants were outstanding and exercisable
at March 31, 2026:
| Issue Date | | Expiry Date | | Exercise Price | | | Number of Warrants Outstanding | | | Number of Warrants Exercisable | | | August 20, 2024 | | August 20, 2026 | | $ | 1,867.97 | | | | 134 | | | | 134 | | | December 24, 2024 | | December 24, 2029 | | $ | 99.63 | | | | 20,075 | | | | 20,075 | | | December 24, 2024 | | December 24, 2026 | | $ | 99.63 | | | | 20,075 | | | | 20,075 | | | December 24, 2024 | | December 24, 2029 | | $ | 124.53 | | | | 1,506 | | | | 1,506 | |
|